Resources 
    • About Us 

    • Home Report Store Diagnostic Specialty Antibodies Market
    Diagnostic Specialty Antibodies Market

    Diagnostic Specialty Antibodies Market by Type (Primary, Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB, Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria, Hepatitis, HIV, E. coli , Tuberculosis, Pneumonia, Cancer)- Forecast to 2029

    Report ID:MRHC - 104554 Pages: 290 Apr-2022 Formats*: PDF Category: Healthcare Delivery: 2 to 4 Hours

    The Diagnostic Specialty Antibodies Market is expected to grow at a CAGR of 4.6% from 2022–2029 to reach $39.99 billion by 2029. Antibodies are used for therapeutic and diagnostic purposes. In diagnosis procedures, the sample containing antigens binds to the antibodies and assists in the diagnosis procedure. Diagnostic antibodies are used in the diagnosis of both infectious and chronic diseases. It is widely used in diagnosing cancer and infectious diseases. Additionally, it is used in pregnancy detection and for monitoring drug action in the body.

    The increasing incidences of infectious diseases, cancer, autoimmune diseases, and pregnancy, the availability of funding for diagnosis of various diseases by different organizations, increasing number of fundings for clinical trials involving the use of diagnostic antibodies, and product approvals of test kits containing diagnostic antibodies are factors driving the growth of this market.

    In addition, the high prevalence of diseases in emerging countries and the initiatives by the public and private organizations for improving the diagnosis activities for eradicating infectious diseases are expected to offer significant opportunities for the growth of this market.

    Diagnostic Specialty Antibodies Market

                                                             Click here to: Get Free Request Sample Copy of this report

    COVID-19 Impact Assessment

    The outbreak of the COVID-19 pandemic impacted the diagnostic specialty antibodies market both positively and negatively. The surge in COVID-19 cases increased the demand for point-of-care test kits containing antibodies due to their capability to provide faster results than other testing methods. To perform mass testing, public organizations in various countries purchased a considerable number of test kits. For instance, the WHO in September 2020, partnered with Africa Centers for Disease Control and Prevention (Africa CDC), Access to covid-19 Tools (ACT) Accelerator, the Clinton Health Access Initiative (CHAI), the Bill & Melinda Gates Foundation, the Foundation for Innovative New Diagnostics (FIND), the Global Fund, and UNITAID for providing COVID-19 antigen test kits to the low and middle-income countries.

    Similarly, the European Commission in December 2020 signed an agreement with F. Hoffmann-La Roche AG (Switzerland) and Abbott Laboratories (U.S.) for purchasing 20 million rapid antigen tests for mass testing the EU Member States. The expected third wave of COVID-19 is further expected to increase the demand for antibody-based testing in the future.

    The number of unintended pregnancies increased significantly worldwide due to the disruptions caused by the COVID-19 pandemic. The UN Population Fund on 11th March 2021 reported that around 12 million women did not have access to contraceptives during the pandemic due to mobility restrictions, supply chain disruptions, and the reluctance of people to visit hospitals and clinics in fear of developing an infection. The UN Population Fund stated that this problem is expected to cause 1.4 million unintended pregnancies in 2021 globally.

    Regulatory authorities worldwide are actively providing approval to antibody-based test kits to support the mass screening across countries. These initiatives are further expected to have a positive impact on the market.

    However, the temporary supply chain disruption due to nationwide lockdowns led to the shortage of test kits across numerous countries; thus, such disruptions hindered the growth of this market to a notable extent.

    Public and Private Organization Initiatives to Eradicate Infectious Diseases is Projected to Drive the Adoption of Diagnostic Antibody

    Various organizations are actively involved in eradicating infectious diseases by improving diagnostic testing; this initiative is expected to drive the adoption of diagnostic antibodies for testing.

    Some of the notable initiatives for disease eradication are given below:

    • The U.S. government, in the Fiscal Year 2021, funded $332 million for the TB control programs globally. The funding was used in more than 50 countries, including 20 of the 30 high burden countries. This funding is used for the prevention, detection, treatment, and R&D of TB.
    • In 2021, the European Commission announced the ‘Europe’s Beating Cancer Plan.’ The plan included four key action areas. One of the key areas was early detection of cancer by improving access to better diagnostics and supporting the member states by ensuring that 90% of the EU population who are expected to have breast, cervical, and colorectal cancer are provided better services in diagnosis by 2025.
    • In 2020, the CDC announced the strategic plan to eradicate hepatitis in the U.S. till 2030. The plan was aimed at developing and promoting hepatitis testing in the country.
    • The U.S. Department of Health and Human Services (HHS), in 2019, announced the ‘Ending the HIV Epidemic in the U.S.’ plan. This initiative was aimed at eradicating HIV disease in the U.S. by 2030. This plan was launched to improve HIV prevention, diagnosis, and treatments.

    Growing Prevalence of Diseases in Emerging Countries to Positively Impact Market

    The high burden of diseases in emerging countries is expected to increase the demand for antibody-based test kits. According to the Cancer Tomorrow estimates, the number of cancer cases in China was estimated to be 4.57 million in 2020, and this number is projected to rise to 6.85 million in 2040. Similarly, the number of cancer cases in Brazil was estimated to rise to 995,000 by 2040 from 592,000 in 2020.

    Furthermore, the International Diabetes Federation (IDF) estimated that in Mexico, 12.8 million cases of diabetes were reported in 2019, and this number is expected to increase to 22.3 million by 2045. Thus, the high prevalence of diseases is expected to increase the number of testing and positively impact market growth.

     

    Key Findings in the Global Diagnostic Specialty Antibodies Market Study:

    The Primary Antibody Segment Estimated to Generate Larger Proportion of Revenue in 2022

    Primary antibodies are highly preferred over secondary antibodies due to their capability to directly bind with the targeted antigen. In addition, primary antibodies can recognize post-translational modifications (PTMs), such as glycosylation, phosphorylation, methylation, or acetylation. Furthermore, primary antibodies are mandatorily used in almost all assays. Hence, these factors attribute to the large market share of this segment.

    Recombinant Antibody Segment Projected to Grow at Fastest CAGR During Forecast Period

    Recombinant antibodies are more cost-effective than monoclonal antibodies and have a better affinity for binding to the target antigen. Also, recombinant monoclonal antibodies are produced in a shorter duration than other clonal antibodies. Hence, these factors drive its demand in the market.

    ELISA Segment Expected to Account for the Largest Share in 2022

    ELISA has a higher specificity, efficiency, and sensitivity and is relatively simple compared to western blot and other assays. These are the key factors promoting the demand for the ELISA technique. In addition, this test is also more cost-effective than IHC, western blot, and other assays, which further drives its demand in the market.

    Unconjugated Antibodies Segment Expected to Grow at Fastest CAGR During Forecast Period

    The specificity and sensitivity of unconjugated antibody is the prime factor driving its demand in the market. Furthermore, the demand for unconjugated antibodies for developing secondary antibody conjugates contributes to the growth of this segment.

    Infectious Diseases Segment Expected to Account for Largest Share in 2022

    The growth of the infectious diseases segment is attributed to the rising incidences of infectious diseases globally, resulting in the demand for diagnostic testing. The growing trend of self-testing kits and the increasing number of regulatory approvals of test kits for infectious diseases testing further contribute to the growth of this segment.

    Asia-Pacific: Fastest growing regional market

    The high market growth rate is attributed to the rising prevalence of diseases and the increasing incidences of unintended pregnancies in the region. In addition, factors such as funding availability for improving diagnosis and the rising number of government initiatives to eradicate infectious diseases, developments in the market, including product approvals and distribution agreements for antibody-based test kits, have further boosted the growth of this market in the region.

    Key Players

    The report includes a competitive landscape based on an extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past three years. The key players profiled in the global diagnostic specialty antibodies market report are Abcam plc (U.K.), F. Hoffman La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Rockland Immunochemicals, Inc. (U.S.), Santa Cruz Biotechnology (U.S.), Novus Biologicals, LLC (U.S.), and Thermo Fisher Scientific Inc. (U.S.).

    Scope of the Report:

    Diagnostic Specialty Antibodies Market, by Type

    • Primary Antibodies
    • Secondary Antibodies

    Diagnostic Specialty Antibodies Market, by Clonality

    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Recombinant Antibodies

    Diagnostic Specialty Antibodies Market, by Technique

    • ELISA
    • Lateral Flow Assay
    • Immunohistochemistry (IHC)
    • Immunoprecipitation (IP)
    • Western Blot (WB)
    • Immunocytochemistry (ICC)
    • Other Techniques
      (Other techniques include immunofluorescence, flow cytometry, in situ hybridization, dot blot, radioimmunoassay, and others)

    Diagnostic Specialty Antibodies Market, by Conjugate

    • Conjugated Antibodies
    • Unconjugated Antibodies

    Diagnostic Specialty Antibodies Market, by Application

    • Infectious Diseases
      • Respiratory Infections
        • COVID-19
        • Influenza
        • Tuberculosis (TB)
        • Pneumonia
        • Other Respiratory Infections
          (Other respiratory infections include strep infections, pertussis, and respiratory syncytial virus (RSV), among others)
      • Parasitic Infections
        • Dengue
        • Malaria
        • Other Parasitic Infections
          (Other parasitic infections include leishmaniasis and zika, among others)
      • Gastrointestinal Infections (GI Infections)
        • Salmonellosis
        • Coli Infections
        • Other GI Infections
          (Other GI infections include cholera, Helicobacter pylori (H. pylori), and campylobacteriosis, among others)
      • Blood Borne Diseases
        • Hepatitis
        • HIV
        • Other Blood-Borne Infections
          (Other blood-borne infections include syphilis, chlamydia, and gonorrhea, among others)
      • Other Infectious Diseases
        (Other infectious diseases include sepsis, rubella, impetigo, and others)
    • Oncology
    • Pregnancy Detection/Fertility Testing
    • Other Applications
      (Other applications include Alzheimer’s, autoimmune diseases and cardiac diseases, diabetes, and others)

    Diagnostic Specialty Antibodies Market, by Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia-Pacific (APAC)
      • China
      • Japan
      • India
      • Rest of APAC (RoAPAC)
    • Latin America
    • Middle East & Africa

    Key questions answered in the report:

    This study offers a detailed assessment of the diagnostic specialty antibodies market, including the market sizes and forecasts of the diagnostic specialty antibodies market segmented based on type, clonality, technique, conjugate, and application. The diagnostic specialty antibodies market studied in this report also involves the value analysis of various segments and subsegments of diagnostic specialty antibodies at the regional and country levels.

    The global diagnostic specialty antibodies market is projected to reach $39.99 billion by 2029, at a CAGR of 4.6% during the forecast period.

    Based on type, the primary antibody segment is estimated to hold the largest share in 2022. The largest share is attributed to the high preference of primary antibodies in diagnosis assays over secondary antibodies due to their capability to directly bind to the targeted antigen. In addition, the regulatory approvals of primary antibody-based kits further increase the growth of this segment.

    The recombinant segment is estimated to grow at the fastest CAGR during the forecast period. Recombinant antibodies are more cost-effective than monoclonal antibodies and have a better affinity for binding to the target antigen. In addition, recombinant monoclonal antibodies are produced in a shorter duration and have higher reproducibility over other clonal antibodies. These factors contribute to its demand in the market.

    The growth of this market is mainly attributed to the growing prevalence of diseases worldwide and their burden on the economy, the increasing usage of diagnostic antibodies in research studies, the availability of funding for research, the increasing number of regulatory approvals of diagnostic test kits containing antibodies, and the rising incidences of unintended pregnancies worldwide. In addition, the initiatives taken by numerous public and private organizations to enhance diagnostic testing to eradicate infectious diseases and the growing incidences of diseases in emerging countries are expected to offer significant growth opportunities to the existing market players and new entrants in the global diagnostic specialty antibodies market.

    The key players operating in the global diagnostic specialty antibodies market include Abcam plc (U.K.), F. Hoffman La Roche Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), Creative Diagnostics (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Rockland Immunochemicals, Inc. (U.S.), Santa Cruz Biotechnology (U.S.), Novus Biologicals, LLC (U.S.), and Thermo Fisher Scientific Inc . (U.S.).

    Emerging economies from Asia, such as China and India, are projected to offer significant growth opportunities for the players operating in this market due to the growing prevalence of diseases in these countries and their high economic burden on the people, the increasing number of fundings and investments for diagnostic activities, and the high incidences of unintended pregnancies.

    Enquire
    Check Discount
    Related Tag: Diagnostic Specialty Antibodies Market Diagnostic Antibody Infectious Disease Diagnostics Monoclonal Ab Polyclonal Ab Diagnostic Antibodies Diagnostic Specialty Antibodies
    In Vitro Diagnostics
    Healthcare

    1.    Introduction 
           1.1.    Market Definition 
           1.2.    Market Ecosystem 
           1.3.    Currency 
           1.4.    Key Stakeholders 

    2.    Research Methodology 
           2.1.    Research Process 
           2.2.    Data Collection & Validation 
                     2.2.1.    Secondary Research 
                     2.2.2.    Primary Research 
           2.3.    Market Assessment 
                     2.3.1.    Market Size Estimation 
                                  2.3.1.1.        Bottom-up Approach 
                                  2.3.1.2.        Top-down Approach 
                                  2.3.1.3.        Growth Forecast 
                     2.3.2.    Market Share Analysis 
           2.4.    Assumptions for this Study 
           2.5.    Limitations for the Study 

    3.    Executive Summary 

    4.    Market Insights 
           4.1.    Introduction 
           4.2.    Drivers 
                     4.2.1.    High Burden of Infectious and Chronic Diseases Globally 
                     4.2.2.    Increasing Funding for Clinical Trials and Research 
                     4.2.3.    Increasing Use of Immunoassays in Oncology 
                     4.2.4.    Technological Advancements in Immunoassays 
                     4.2.5.    Growing Demand for Pregnancy Testing Owing to Self-testing and Restricted Use of Contraceptives 
           4.3.    Restraints 
                     4.3.1.    Use of Substitute Tests for Diagnosis 
                     4.3.2.    The Availability of Vaccines for Diseases Like Hepatitis, Tuberculosis, Influenza, Malaria, and Dengue 
           4.4.    Opportunities
                     4.4.1.    Initiatives by Public and Private Organizations to Increase Diagnostic Testing 
                     4.4.2.    Emerging Economies 
           4.5.    Challenges 
                     4.5.1.    Misleading Results With Antibody Tests 
                     4.5.2.    High Cost of Manufacturing Antibodies 
           4.6.    Impact of COVID-19 on the Diagnostic Specialty Antibodies Market 

    5.    Global Diagnostic Specialty Antibodies Market, by Type 
           5.1.    Introduction 
           5.2.    Primary Antibodies 
           5.3.    Secondary Antibodies 

    6.    Global Diagnostic Specialty Antibodies Market, by Clonality 
           6.1.    Introduction 
           6.2.    Monoclonal Antibodies 
           6.3.    Polyclonal Antibodies 
           6.4.    Recombinant Antibodies 

    7.    Global Diagnostic Specialty Antibodies Market, by Application 
           7.1.    Introduction 
           7.2.    Infectious Diseases 
                     7.2.1.    Respiratory Infections 
                                  7.2.1.1.        COVID-19 
                                  7.2.1.2.        Pneumonia 
                                  7.2.1.3.        Influenza 
                                  7.2.1.4.        Tuberculosis (TB) 
                                  7.2.1.5.        Other Respiratory Infections
                     7.2.2.    Parasitic Infections 
                                  7.2.2.1.        Dengue 
                                  7.2.2.2.        Malaria 
                                  7.2.2.3.        Other Parasitic Infections 
                     7.2.3.    Gastrointestinal (GI) Infections 
                                  7.2.3.1.        Salmonellosis 
                                  7.2.3.2.        E. coli Infections 
                                  7.2.3.3.        Other GI Infections 
                     7.2.4.    Blood-borne Infections 
                                  7.2.4.1.        Hepatitis 
                                  7.2.4.2.        HIV
                                  7.2.4.3.        Other Blood-borne Infections 
                     7.2.5.    Other Infectious Diseases 
           7.3.    Oncology 
           7.4.    Pregnancy Detection/Fertility Testing 
           7.5.    Cardiac Marker Testing 
           7.6.    Other Applications 

    8.    Global Diagnostic Specialty Antibodies Market, by Technique 
           8.1.    Introduction 
           8.2.    ELISA 
           8.3.    Lateral Flow Assay 
           8.4.    Immunohistochemistry (IHC) 
           8.5.    Immunoprecipitation (IP) 
           8.6.    Western Blot (WB) 
           8.7.    Immunocytochemistry (ICC) 
           8.8.    Other Techniques 

    9.    Global Diagnostic Specialty Antibodies Market, by Conjugate 
           9.1.    Introduction 
           9.2.    Unconjugated Antibodies 
           9.3.    Conjugated Antibodies 

    10.   Diagnostic Specialty Antibodies Market, by Geography 
             10.1.    Introduction 
             10.2.    North America 
                         10.2.1.    U.S. 
                         10.2.2.    Canada 
             10.3.    Europe 
                         10.3.1.    Germany 
                         10.3.2.    France 
                         10.3.3.    U.K. 
                         10.3.4.    Italy 
                         10.3.5.    Spain 
                         10.3.6.    Rest of Europe (RoE) 
             10.4.    Asia-Pacific 
                         10.4.1.    China 
                         10.4.2.    Japan 
                         10.4.3.    India 
                         10.4.4.    Rest of Asia-Pacific (RoAPAC) 
             10.5.    Latin America 
             10.6.    Middle East & Africa 

    11.    Competitive Landscape 
             11.1.    Introduction 
             11.2.    Key Growth Strategies 
             11.3.    Competitive Benchmarking 
             11.4.    Market Share Analysis (2020) 
                        11.4.1.    F. Hoffmann-La Roche 
                        11.4.2.    Thermo Fisher Scientific, Inc. 
                        11.4.3.    Merck KGaA 

    12.    Company Profiles 
             12.1.    Abcam Plc 
                         12.1.1.    Business Overview 
                         12.1.2.    Financial Overview 
                         12.1.3.    Product Benchmarking 
                         12.1.4.    Strategic Developments 
             12.2.    F. Hoffmann-La Roche Ltd 
                         12.2.1.    Business Overview 
                         12.2.2.    Financial Overview 
                         12.2.3.    Product Portfolio  
             12.3.    Bio-Rad Laboratories, Inc. 
                         12.3.1.    Business Overview 
                         12.3.2.    Financial Overview 
                         12.3.3.    Product Portfolio 
                         12.3.4.    Strategic Developments 
             12.4.    Creative Diagnostics 
                         12.4.1.    Business Overview 
                         12.4.2.    Product Portfolio 
                         12.4.3.    Strategic Developments 
             12.5.    Merck KGaA 
                         12.5.1.    Business Overview 
                         12.5.2.    Financial Overview 
                         12.5.3.    Product Portfolio 
             12.6.    Agilent Technologies, Inc. 
                         12.6.1.    Business Overview 
                         12.6.2.    Financial Overview 
                         12.6.3.    Product Portfolio 
                         12.6.4.    Strategic Developments 
             12.7.    Becton, Dickinson and Company 
                         12.7.1.    Business Overview 
                         12.7.2.    Financial Overview 
                         12.7.3.    Product Portfolio 
             12.8.    Rockland Immunochemicals, Inc 
                         12.8.1.    Business Overview 
                         12.8.2.    Product Portfolio 
                         12.8.3.    Strategic Developments 
             12.9.    Santa Cruz Biotechnology, Inc 
                         12.9.1.    Business Overview 
                         12.9.2.    Product Portfolio 
             12.10.   Novus Biologicals, Llc 
                         12.10.1.    Business Overview 
                         12.10.2.    Financial Overview 
                         12.10.3.    Product Portfolio 
             12.11.    Thermo Fisher Scientific Inc. 
                         12.11.1.    Business Overview 
                         12.11.2.    Financial Overview 
                         12.11.3.    Product Portfolio 

    13.    Appendix 
             13.1.    Questionnaire 
             13.2.    Available Customization 

    List of Tables

    Table 1    Global Diagnostic Specialty Antibodies Market Drivers: Impact Analysis (2022–2029) 
    Table 2    Research Funding 
    Table 3    Cancer Biomarkers for Immunoassay 
    Table 4    Global Diagnostic Specialty Antibodies Market Restraints: Impact Analysis (2022–2029) 
    Table 5    Recent Initiatives for Improving Diseases Diagnosis 
    Table 6    Recent COVID-19 Test Kit Approvals 
    Table 7    Global Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 8    Global Primary Diagnostic Specialty Antibodies Market Size, by Country/Region, 2020–2029 (USD Million) 
    Table 9    Global Secondary Diagnostic Specialty Antibodies Market Size, by Country/Region, 2020–2029 (USD Million) 
    Table 10    Global Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 11    Global Diagnostic Monoclonal Antibodies Market, by Country/Region, 2020–2029 (USD Million) 
    Table 12    Global Diagnostic Polyclonal Antibodies Market Size, by Country/Region, 2020–2029 (USD Million) 
    Table 13    Global Diagnostic Recombinant Antibodies Market Size, by Country/Region, 2020–2029 (USD Million) 
    Table 14    Global Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 15    Global Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 16    Global Diagnostic Specialty Antibodies Market Size for Infectious Diseases, By Country/Region, 2020–2029 (USD Million) 
    Table 17    Global Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 18    Global Diagnostic Specialty Antibodies Market Size for Respiratory Infections, By Country/ Region, 2020–2029 (USD Million) 
    Table 19    COVID-19 Testing by Country 
    Table 20    List of Emergency Use Authorizations (EUA) From The U.S. FDA for Test Kits Containing Antibodies 
    Table 21    List of Product Launches of Antibodies-based Test Kits 
    Table 22    List of Product Launches of Test Kits for Specific Country 
    Table 23    Global Diagnostic Specialty Antibodies Market Size for COVID-19, by Country/Region, 2020–2029 (USD Million) 
    Table 24    Global Diagnostic Specialty Antibodies Market Size for Pneumonia, by Country/Region, 2020–2029 (USD Million) 
    Table 25    Global Diagnostic Specialty Antibodies Market Size for Influenza, by Country/Region, 2020–2029 (USD Million) 
    Table 26    Global Diagnostic Specialty Antibodies Market Size for Tuberculosis, by Country/Region, 2020–2029 (USD Million) 
    Table 27    Global Diagnostic Specialty Antibodies Market Size for Other Respiratory Infections, By Country/Region, 2020–2029 (USD Million) 
    Table 28    Global Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 29    Global Diagnostic Specialty Antibodies Market Size for Parasitic Infections, By Country/Region, 2020–2029 (USD Million) 
    Table 30    Global Diagnostic Specialty Antibodies Market Size for Dengue by Country/Region, 2020–2029 (USD Million) 
    Table 31    Global Diagnostic Specialty Antibodies Market Size for Malaria by Country/Region, 2020–2029 (USD Million) 
    Table 32    Global Diagnostic Specialty Antibodies Market Size for Other Parasitic Infections, By Country/Region, 2020–2029 (USD Million) 
    Table 33    Global Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 34    Global Diagnostic Specialty Antibodies Market Size for GI Infections, by Country/Region, 2020–2029 (USD Million) 
    Table 35    Global Diagnostic Specialty Antibodies Market Size for Salmonellosis, by Country/ Region, 2020–2029 (USD Million) 
    Table 36    Global Diagnostic Specialty Antibodies Market Size for E. coli Infections, by Country/ Region, 2020–2029 (USD Million) 
    Table 37    Global Diagnostic Specialty Antibodies Market Size for Other GI Infections, by Country/ Region, 2020–2029 (USD Million) 
    Table 38    Global Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 39    Global Diagnostic Specialty Antibodies Market Size for Blood-borne InfectionsBy Country/Region, 2020–2029 (USD Million) 
    Table 40    Global Diagnostic Specialty Antibodies Market Size for Hepatitis, by Country/Region, 2020–2029 (USD Million) 
    Table 41    Global Diagnostic Specialty Antibodies Market Size for HIV , by Country/Region, 2020–2029 (USD Million) 
    Table 42    Global Diagnostic Specialty Antibodies Market Size for Other Blood-borne Infections , By Country/Region, 2020–2029 (USD Million) 
    Table 43   Global Diagnostic Specialty Antibodies Market Size for Other Infectious Diseases By Country/Region, 2020–2029 (USD Million) 
    Table 44   Global Diagnostic Specialty Antibodies Market Size for Oncology, by Country/Region, 2020–2029 (USD Million) 
    Table 45   Estimated Number of Births in 2020 
    Table 46  Global Diagnostic Specialty Antibodies Market Size for Pregnancy Detection/Fertility Testing, by Country/Region, 2020–2029 (USD Million) 
    Table 47    Global Diagnostic Specialty Antibodies Market Size for Cardiac Marker Testing, By Country/Region, 2020–2029 (USD Million) 
    Table 48    Global Diagnostic Specialty Antibodies Market Size for Other Applications, By Country/Region, 2020–2029 (USD Million) 
    Table 49    Global Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 50    Global Diagnostic Specialty Antibodies Market Size for ELISA, by Country/Region, 2020–2029 (USD Million) 
    Table 51    Global Diagnostic Specialty Antibodies Market Size for Lateral Flow Assay, By Country/Region, 2020–2029 (USD Million) 
    Table 52    Global Diagnostic Specialty Antibodies Market Size for Immunohistochemistry, By Country/Region, 2020–2029 (USD Million) 
    Table 53    Global Diagnostic Specialty Antibodies Market Size for Immunoprecipitation, By Country/Region, 2020–2029 (USD Million) 
    Table 54    Global Diagnostic Specialty Antibodies Market Size for Western Blot, by Country/Region, 2020–2029 (USD Million) 
    Table 55    Global Diagnostic Specialty Antibodies Market Size Immunocytochemistry, By Country/Region, 2020–2029 (USD Million) 
    Table 56    Global Diagnostic Specialty Antibodies Market Size for Other Techniques, By Country/Region, 2020–2029 (USD Million) 
    Table 57    Global Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 58    Global Unconjugated Diagnostic Specialty Antibodies Market, by Country/Region, 2020–2029 (USD Million) 
    Table 59    Global Conjugated Diagnostic Specialty Antibodies Market Size, by Country/Region, 2020–2029 (USD Million) 
    Table 60    Global Diagnostic Specialty Antibodies Market Size, by Country/Region, 2020–2029 (USD Million) 
    Table 61    North America: Diagnostic Specialty Antibodies Market Size, by Country, 2020–2029 (USD Million) 
    Table 62    North America: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 63    North America: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 64    North America: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 65    North America: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 66    North America: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 67    North America: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, By Type, 2020–2029 (USD Million) 
    Table 68    North America: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, By Type, 2020–2029 (USD Million) 
    Table 69    North America: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 70    North America: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 71    North America: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, By Type, 2020–2029 (USD Million) 
    Table 72    List of Products Received Emergency Use Authorization From U.S. FDA 
    Table 73    Funding Provided by The National Cancer Institute for Researchers in 2018 By Disease Areas 
    Table 74    List of Antibodies Launched for Diagnostic Purposes in the U.S 
    Table 75    U.S.: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 76    U.S.: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 77    U.S.: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 78    U.S.: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 79    U.S.: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 80    U.S.: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 81    U.S.: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 82    U.S.: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 83    U.S.: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 84    U.S.: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 85    Recent Health Canada Approvals for SARS-CoV-2 Test Kits (2020–2021) 
    Table 86    Canada: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 87    Canada: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 88    Canada: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 89    Canada: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 90    Canada: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 91    Canada: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 92    Canada: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 93    Canada: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 94    Canada: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 95    Canada: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 96    Europe: Diagnostic Specialty Antibodies Market Size, by Country, 2020–2029 (USD Million) 
    Table 97    Europe: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 98    Europe: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 99    Europe: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 100    Europe: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 101    Europe: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 102    Europe: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 103    Europe: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 104    Europe: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 105    Europe: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 106    Europe: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 107    Germany: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 108    Germany: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 109    Germany: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 110    Germany: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 111    Germany: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 112    Germany: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 113    Germany: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 114    Germany: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 115    Germany: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 116    Germany: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 117    France: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 118    France: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 119    France: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 120    France: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 121    France: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 122    France: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 123    France: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 124    France: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 125    France: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 126    France: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 127    U.K.: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 128    U.K.: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 129    U.K.: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 130    U.K.: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 131    U.K.: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 132    U.K.: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 133    U.K.: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 134    U.K.: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 135    U.K.: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 136    U.K.: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 137    Italy: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 138    Italy: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 139    Italy: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 140    Italy: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 141    Italy: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 142    Italy: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 143    Italy: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 144    Italy: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 145    Italy: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 146    Italy: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 147    Spain: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 148    Spain: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 149    Spain: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 150    Spain: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 151    Spain: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 152    Spain: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 153    Spain: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 154    Spain: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 155    Spain: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 156    Spain: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 157    Incidence of COVID-19 in RoE Countries (Cases As of 21st December 2021) 
    Table 158    Healthcare Expenditure % Contribution to GDP 
    Table 159    Rest of Europe: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 160    Rest of Europe: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 161    Rest of Europe: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 162    Rest of Europe: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 163    Rest of Europe: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 164    Rest of Europe: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 165    Rest of Europe: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, By Type, 2020–2029 (USD Million) 
    Table 166    Rest of Europe: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 167    Rest of Europe: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 168    Rest of Europe: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, By Type, 2020–2029 (USD Million) 
    Table 169    Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Country, 2020–2029 (USD Million) 
    Table 170    Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 171    Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 172    Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 173    Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 174    Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 175    Asia-Pacific: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 176    Asia-Pacific: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 177    Asia-Pacific: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 178    Asia-Pacific: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 179    Asia-Pacific: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, By Type, 2020–2029 (USD Million) 
    Table 180    China: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 181    China: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 182    China: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 183    China: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 184    China: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 185    China: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 186    China: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 187    China: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 188    China: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 189    China: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 190    Regulatory Approvals for Antigen Test Kits for COVID-19 in Japan 
    Table 191    Japan: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 192    Japan: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 193    Japan: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 194    Japan: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 195    Japan: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 196    Japan: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 197    Japan: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 198    Japan: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 199    Japan: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 200    Japan: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 201    List of Regulatory Approvals for COVID-19 Test Kits Containing Antibodies From The Indian Council of Medical Research (ICMR) 
    Table 202    List of Product Launches of COVID-19 Test Kits Containing Antibodies 
    Table 203    India: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 204    India: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 205    India: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 206    India: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 207    India: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 208    India: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 209    India: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 210    India: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 211    India: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 212    India: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 213    Total COVID-19 Cases (As of 21st December 2021) 
    Table 214    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 215    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 216    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 217    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 218    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 219    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, By Type, 2020–2029 (USD Million) 
    Table 220    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 221    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, By Type, 2020–2029 (USD Million) 
    Table 222    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 223    Rest of Asia-Pacific: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 224    Latin America Total COVID-19 Cases (As of 21st December 2021) 
    Table 225    Latin America: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 226    Latin America: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 227    Latin America: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 228    Latin America: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 229    Latin America: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 230    Latin America: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 231    Latin America: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, By Type, 2020–2029 (USD Million) 
    Table 232    Latin America: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, by Type, 2020–2029 (USD Million) 
    Table 233    Latin America: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 234    Latin America: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, By Type, 2020–2029 (USD Million) 
    Table 235    COVID-19 Cases in the MEA Region (As of 15th December 2021) 
    Table 236    Middle East & Africa: Diagnostic Specialty Antibodies Market Size, by Type, 2020–2029 (USD Million) 
    Table 237    Middle East & Africa: Diagnostic Specialty Antibodies Market Size, by Clonality, 2020–2029 (USD Million) 
    Table 238    Middle East & Africa: Diagnostic Specialty Antibodies Market Size, by Technique, 2020–2029 (USD Million) 
    Table 239    Middle East & Africa: Diagnostic Specialty Antibodies Market Size, by Conjugate, 2020–2029 (USD Million) 
    Table 240    Middle East & Africa: Diagnostic Specialty Antibodies Market Size, by Application, 2020–2029 (USD Million) 
    Table 241    Middle East & Africa: Diagnostic Specialty Antibodies Market Size for Infectious Diseases, by Type, 2020–2029 (USD Million) 
    Table 242    Middle East & Africa: Diagnostic Specialty Antibodies Market Size for Respiratory Infections, by Type, 2020–2029 (USD Million) 
    Table 243    Middle East & Africa: Diagnostic Specialty Antibodies Market Size for Parasitic Infections, By Type, 2020–2029 (USD Million) 
    Table 244    Middle East & Africa: Diagnostic Specialty Antibodies Market Size for GI Infections, by Type, 2020–2029 (USD Million) 
    Table 245    Middle East & Africa: Diagnostic Specialty Antibodies Market Size for Blood-borne Infections, by Type, 2020–2029 (USD Million) 
    Table 246    Recent Developments, by Company, 2018—2021 

    List of Figures

    Figure 1    Research Process 
    Figure 2    Key Secondary Sources 
    Figure 3    Primary Research Techniques 
    Figure 4    Key Executives Interviewed 
    Figure 5    Breakdown of Primary Interviews (Supply-side & Demand-side) 
    Figure 6    Market Size Estimation 
    Figure 7    Global Diagnostic Specialty Antibodies Market Size, by Type, 2022–2029 (USD Million) 
    Figure 8    Global Diagnostic Specialty Antibodies Market Size, by Clonality, 2022–2029 (USD Million) 
    Figure 9    Global Diagnostic Specialty Antibodies Market Size, by Technique, 2022–2029 (USD Million) 
    Figure 10    Global Diagnostic Specialty Antibodies Market Size, by Conjugate, 2022–2029 (USD Million) 
    Figure 11    Global Diagnostic Specialty Antibodies Market Size, by Application, 2022–2029 (USD Million) 
    Figure 12    Global Diagnostic Specialty Antibodies Market Size, by Geography 
    Figure 13    Market Dynamics 
    Figure 14    Estimated Incidence Rate for Different Types of Cancer in 2020 
    Figure 15    Global Diagnostic Specialty Antibodies Market Size, by Type, 2022–2029 (USD Millions) 
    Figure 16    Global Diagnostic Specialty Antibodies Market Size, by Clonality, 2022–2029 (USD Million) 
    Figure 17    Global Diagnostic Specialty Antibodies Market Size, by Application, 2022–2029 (USD Million) 
    Figure 18    Global Diagnostic Specialty Antibodies Market Size, by Technique, 2022–2029, (USD Million) 
    Figure 19    Global Diagnostic Specialty Antibodies Market Size, by Conjugate, 2022–2029 (USD Million) 
    Figure 20    Global Diagnostic Specialty Antibodies Market Size, by Region, 2022–2029 (USD Million) 
    Figure 21    Geographic Snapshot: North America Diagnostic Specialty Antibodies Market 
    Figure 22    Geographic Snapshot: Europe Diagnostic Specialty Antibodies Market 
    Figure 23    Estimated Percentage of New Cancer Cases in Spain (2020) 
    Figure 24    Geographic Snapshot: Asia-Pacific Diagnostic Specialty Antibodies Market 
    Figure 25    COVID-19 Vaccination Status in MEA Region 
    Figure 26    Key Growth Strategies Adopted by Leading Players, 2018–2021 
    Figure 27    Diagnostic Specialty Antibodies Market: Competitive Benchmarking (Based on Type) 
    Figure 28    Diagnostic Specialty Antibodies Market: Competitive Benchmarking (Based on Clonality) 
    Figure 29    Diagnostic Specialty Antibodies Market: Competitive Benchmarking (Based on Conjugation) 
    Figure 30    Diagnostic Specialty Antibodies Market: Competitive Benchmarking (Based on Geography)
    Figure 31    Market Share Analysis: Diagnostic Specialty Antibodies Market, 2020 
    Figure 32    Abcam Plc: Financial Snapshot, 2020 
    Figure 33    F. Hoffman-La Roche AG Ltd: Financial Snapshot, 2020 
    Figure 34    Bio-Rad Laboratories, Inc.: Financial Snapshot, 2020 
    Figure 35    Merck KGaA: Financial Overview, 2020 
    Figure 36    Agilent Technologies, Inc: Financial Snapshot, 2020 
    Figure 37    Becton, Dickinson and Company: Financial Snapshot, 2021 
    Figure 38    Bio-Techne Corporation: Financial Snapshot, 2021 
    Figure 39    Thermo Fisher Scientific, Inc.: Financial Overview, 2020 

    Enquire
    Check Discount
    Author Name:

    Pranjali Takale, Mahesh Khillari

    Related Tag: Diagnostic Specialty Antibodies Market Diagnostic Antibody Infectious Disease Diagnostics Monoclonal Ab Polyclonal Ab Diagnostic Antibodies Diagnostic Specialty Antibodies
    In Vitro Diagnostics
    Healthcare
      This website is secure and we do not share your personal information with any third party. privacy policy
      You will also receive a PDF copy of this sample in your mailbox.

      Proudly Partnering With Enterprises Around the Globe

      Accenture Amazon BCG-Corporate BioRad Boehringer-Ingelheim Deloitte Fujifilm Intel PEPSICO Samsung Olympus McKinsey LG-Chem Rosetta-Stone tata-consultancy-services SK Kao IQVIA Vemag Canada Genscript Grupo-Vilaseca HEC Highland-Metals-Inc
      Related Tag: Diagnostic Specialty Antibodies Market Diagnostic Antibody Infectious Disease Diagnostics Monoclonal Ab Polyclonal Ab Diagnostic Antibodies Diagnostic Specialty Antibodies
      Request Sample
      Customize My Report
      Quick Contact
      Chat on Whatsapp
      Linkdin
      Whatsapp
      Feed
      Related Reports
      Monoclonal Antibodies Market - Global Opportunity Analysis and Industry Forecast (2024-2031)

         Published Date: Jun-2024

      Research Antibodies and Reagents Market - Global Opportunity Analysis and Industry Forecast (2024-2031)

         Published Date: Mar-2024

      Europe Cancer Diagnostics Market- Opportunity Analysis And Industry Forecast (2024-2031)

         Published Date: Feb-2024

      Veterinary Rapid Diagnostic Tests Market - Global Opportunity Analysis And Industry Forecast (2023-2030)

         Published Date: Apr-2023

      Tissue Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2022-2029)

         Published Date: Nov-2022

      Table Of Content
      Download Free Sample Report
      Meticulous Research
      US
      +1 646-781-8004
      Meticulous Research
      Europe
      +44-203-868-8738
      Meticulous Research
      APAC
      +91-744-778-0008